HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Piperlongumine, an alkaloid causes inhibition of PI3 K/Akt/mTOR signaling axis to induce caspase-dependent apoptosis in human triple-negative breast cancer cells.

Abstract
The phosphatidylinositol 3-kinase (PI3 K)/Akt/mammalian target of rapamycin (mTOR) signaling axis plays a central role in cell proliferation, growth and survival under physiological conditions. However, aberrant PI3 K/Akt/mTOR signaling has been implicated in many human cancers, including human triple negative breast cancer. Therefore, dual inhibitors of PI3 K/Akt and mTOR signaling could be valuable agents for treating breast cancer. The objective of this study was to investigate the effect of piperlongumine (PPLGM), a natural alkaloid on PI3 K/Akt/mTOR signaling, Akt mediated regulation of NF-kB and apoptosis evasion in human breast cancer cells. Using molecular docking studies, we found that PPLGM physically interacts with the conserved domain of PI3 K and mTOR kinases and the results were comparable with standard dual inhibitor PF04691502. Our results demonstrated that treatment of different human triple-negative breast cancer cells with PPLGM resulted in concentration- and time-dependent growth inhibition. The inhibition of cancer cell growth was associated with G1-phase cell cycle arrest and down-regulation of the NF-kB pathway leads to activation of the mitochondrial apoptotic pathway. It was also found that PPLGM significantly decreased the expression of p-Akt, p70S6K1, 4E-BP1, cyclin D1, Bcl-2, p53 and increased expression of Bax, cytochrome c in human triple-negative breast cancer cells. Although insulin treatment increased the phosphorylation of Akt (Ser473), p70S6K1, 4E-BP1, PPLGM abolished the insulin mediated phosphorylation, it clearly indicates that PPLGM acts through PI3 k/Akt/mTOR axis. Our results suggest that PPLGM may be an effective therapeutic agent for the treatment of human triple negative breast cancer.
AuthorsShweta Shrivastava, Prasad Kulkarni, Dinesh Thummuri, Manish Kumar Jeengar, V G M Naidu, Mallika Alvala, G Bhanuprakash Redddy, Sistla Ramakrishna
JournalApoptosis : an international journal on programmed cell death (Apoptosis) Vol. 19 Issue 7 Pg. 1148-64 (Jul 2014) ISSN: 1573-675X [Electronic] Netherlands
PMID24729100 (Publication Type: Journal Article)
Chemical References
  • Alkaloids
  • Dioxolanes
  • Reactive Oxygen Species
  • MTOR protein, human
  • Phosphatidylinositol 3-Kinase
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases
  • Caspases
  • piperlonguminine
Topics
  • Alkaloids (pharmacology)
  • Apoptosis (drug effects)
  • Caspases (metabolism)
  • Cell Cycle Checkpoints (drug effects, genetics)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • DNA Fragmentation (drug effects)
  • Dioxolanes (pharmacology)
  • Female
  • Humans
  • Molecular Docking Simulation
  • Phosphatidylinositol 3-Kinase (metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Reactive Oxygen Species (metabolism)
  • Signal Transduction
  • TOR Serine-Threonine Kinases (metabolism)
  • Triple Negative Breast Neoplasms (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: